We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cigna Corp. (CI - Free Report) is a national health benefits company with a comprehensive portfolio of businesses which includes Employee Healthcare, Disability and Life.
Its organizational efficiency plans as well as expansion of Seniors and Medicare business position it well for long run.
The company has a large international presence, which provides diversification benefits.
Cigna is due to be acquired by Anthem Inc. The merger, however, is wrapped in uncertainty with the DoJ opposing to the merger on grounds that the deal would curb competition in the market.
With respect to earnings surprise, though Cigna surpassed estimates in three of the past four quarters and delivered a negative surprise in only one, its average earnings miss is 1.34%.
Currently, Cigna has a Zacks Rank #3 (Hold), but that could definitely change following Cigna earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below: You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings: Cigna surpassed the earnings estimate. Our consensus called for earning per share of $1.91, and the company reported earnings of $1.94 per share. Earnings per share was, however, down 15% year over year.
Revenue: Operating revenues of $9.81 billion surpassed the Zacks Consensus Estimate of $9.79 billion. Revenues also grew 5% year over year.
Premiums of $7.6 billion increased 3.5% year over year, while mail order pharmacy revenues increased 18.5%
Total Medical Customers totaled 15.2 million as on Sep 30, 2016.
Cigna updated its 2016 earnings guidance. It expects earning per share in the range of $7.80 to $8.05. It expects mid-single digit growth in revenue. The company expects global medical customer growth in low single digits percentage range.
Check back later for our full write up on this CI earnings report later!
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cigna (CI) Beats Q3 Earnings Estimate, Updates Guidance
Cigna Corp. (CI - Free Report) is a national health benefits company with a comprehensive portfolio of businesses which includes Employee Healthcare, Disability and Life.
Its organizational efficiency plans as well as expansion of Seniors and Medicare business position it well for long run.
The company has a large international presence, which provides diversification benefits.
Cigna is due to be acquired by Anthem Inc. The merger, however, is wrapped in uncertainty with the DoJ opposing to the merger on grounds that the deal would curb competition in the market.
With respect to earnings surprise, though Cigna surpassed estimates in three of the past four quarters and delivered a negative surprise in only one, its average earnings miss is 1.34%.
Currently, Cigna has a Zacks Rank #3 (Hold), but that could definitely change following Cigna earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below: You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings: Cigna surpassed the earnings estimate. Our consensus called for earning per share of $1.91, and the company reported earnings of $1.94 per share. Earnings per share was, however, down 15% year over year.
Revenue: Operating revenues of $9.81 billion surpassed the Zacks Consensus Estimate of $9.79 billion. Revenues also grew 5% year over year.
CIGNA CORP Price and EPS Surprise
CIGNA CORP Price and EPS Surprise | CIGNA CORP Quote
Key Stats to Note:
Premiums of $7.6 billion increased 3.5% year over year, while mail order pharmacy revenues increased 18.5%
Total Medical Customers totaled 15.2 million as on Sep 30, 2016.
Cigna updated its 2016 earnings guidance. It expects earning per share in the range of $7.80 to $8.05. It expects mid-single digit growth in revenue. The company expects global medical customer growth in low single digits percentage range.
Check back later for our full write up on this CI earnings report later!
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>